Association of skin cholesterol content, measured by a noninvasive method, with markers of inflammation and Framingham risk prediction.
Mancini
G B John
GB
Lipid Clinic/Healthy Heart Program and the Atherosclerosis Reversal Clinic, St. Paul's Hospital and Jack Bell Research Centre, University of British Columbia, Vancouver, British Columbia, Canada. mancini@interchange.ubc.ca
Chan
Sammy
S
Frohlich
Jiri
J
Kuramoto
Lisa
L
Schulzer
Michael
M
Abbott
David
D
D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D002318:Cardiovascular Diseases; D002784:Cholesterol / Q000032:analysis*; D019040:E-Selectin / Q000097:blood; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012306:Risk; D012307:Risk Factors; D012867:Skin / Q000737:chemistry*; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood
D015415:Biomarkers; D019040:E-Selectin; D008055:Lipids; D019010:Vascular Cell Adhesion Molecule-1; D002097:C-Reactive Protein; D002784:Cholesterol